| Financial Year |
March 31 2023 |
| Monetary Funds |
954,037,322.84 |
| Held-for-trading Financial Assets |
36,932,348.04 |
| Notes Receivable |
237,523,345.42 |
| Accounts Receivable |
742,056,427.40 |
| Advances to Suppliers |
118,235,143.51 |
| Other Receivables |
63,258,986.05 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
645,756,259.33 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,056,542.24 |
| Total Current Assets |
3,551,344,196.55 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
151,127,516.43 |
| Investment Properties |
47,876,182.66 |
| Fixed Assetes |
734,354,753.00 |
| Under-construction Projects |
5,776,558.53 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
134,138,441.08 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,004,006.83 |
| Deferred Income Tax Assets |
53,858,844.08 |
| Other Non-Current Assets |
41,932,314.20 |
| Sub-Total of Non-Current Assets |
1,192,202,634.07 |
| Total Assets |
4,743,546,830.62 |
| Short-Term Loans |
1,701,994,692.67 |
| Trading Financial liabilities |
-- |
| Notes Payable |
72,731,848.18 |
| Accounts Payable |
181,526,291.34 |
| Accounts Received In Advance |
92,312.20 |
| Employee Compensation Payable |
7,694,819.36 |
| Taxes Payable |
16,017,883.13 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
43,905,897.99 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
168,160.43 |
| Other Current Liabilities |
7,751,124.68 |
| Sub-Total of Current Liabilities |
2,091,507,065.92 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
487,686.85 |
| Other Non-Current Liabilities |
5,813,801.10 |
| Sub-Total of Non-Current Liabilities |
7,072,083.34 |
| Total Liabilities |
2,098,579,149.26 |
| Paid-In Capital(Or Share Stock) |
1,142,246,700.00 |
| Capital Surplus |
1,268,341,078.62 |
| Surplus Reserve |
179,621,933.09 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
87,084,763.57 |
| Minority Stockholder's Interest |
21,800,210.37 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,623,167,470.99 |
| Owner's Equity（Stockholder's Equity） |
2,644,967,681.36 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,743,546,830.62 |
